AstraZeneca's heart drug gets FDA nod
AstraZeneca Plc said on Monday the U.S. Food and Drug Administration has approved its drug for reducing the risk of a first heart attack or stroke in high-risk patients with coronary artery disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: AstraZeneca | Cardiology | Food and Drug Administration (FDA) | Health | Heart | Heart Attack | Stroke